Minimal clinical important difference (MCID) on pruritus scales

Minimal clinical important difference (MCID) on pruritus scales - PruMCID

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00005732

Enrollment

250

Registered

2014-03-10

Start date

2011-08-22

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

L29.9

Interventions

Group 1: Patients should fill at three time points (day 1, day 5-14, 4-6 weeks) a questionnaire with questions about the course of symptoms. This relates to the general change of pruritus, the directi

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with chronic itch treated in outpatient and inpatient settings

Exclusion criteria

Exclusion criteria: Patients who cannot fill in the questionnaire (e.g., because of current psychosomatic or psychiatric disease)

Design outcomes

Primary

Measure	Time frame
Determining the MCID (minimal clinical important difference) on the VAS (visual analogue scale) by questionnaire at the time of 5-14 days (time point 2) or 4-6 weeks (time 3) compared to day 0 (time 1)	—

Secondary

Measure	Time frame
Determining the MCID (minimal clinical important difference) on the NRS (Numerical Rating Scale) and VRS (Verbal Rating Scale) by questionnaire at the time of 5-14 days (time point 2) or 4-6 weeks (time 3) compared to day 0 (time 1)	—

Countries

Germany

Contacts

Public ContactSabine Stoll

Klinik für Hautkrankheiten undKompetenzzentrum chronischer Pruritus (KCP)Universitätsklinikum Münster

juckreizambulanz@ukmuenster.de0251-8357470

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026